Immunologic reactivity to herpes simplex virus antigens in seropositive individuals and individuals with recurrent HSV-2 infection:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Buch |
| Sprache: | English |
| Veröffentlicht: |
2007
|
| Schlagworte: | |
| Online-Zugang: | Abstract |
| Beschreibung: | Zsfassung in dt. Sprache |
| Beschreibung: | XI, 158 Bl. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV039632217 | ||
| 003 | DE-604 | ||
| 005 | 20120120 | ||
| 007 | t | ||
| 008 | 111012s2007 au ad|| m||| 00||| eng d | ||
| 035 | |a (OCoLC)918103370 | ||
| 035 | |a (DE-599)OBVAC05035874 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 044 | |a au |c AT | ||
| 049 | |a DE-188 | ||
| 100 | 1 | |a Model, Nina |e Verfasser |4 aut | |
| 242 | 0 | 0 | |a Immunologische Reaktivität gegen Herpes Simplex Virus Antigene in seropositiven Personen und Personen mit wiederkehrender HSV-2 Infektion |y ger |
| 245 | 1 | 0 | |a Immunologic reactivity to herpes simplex virus antigens in seropositive individuals and individuals with recurrent HSV-2 infection |c vorgelegt von Nina Model |
| 264 | 1 | |c 2007 | |
| 300 | |a XI, 158 Bl. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Zsfassung in dt. Sprache | ||
| 502 | |a Wien, Univ., Diss., 2007 | ||
| 650 | 7 | |a viral diseases |2 cabt | |
| 650 | 7 | |a herpesviridae |2 cabt | |
| 650 | 7 | |a biotechnology |2 cabt | |
| 650 | 7 | |a varicellovirus |2 cabt | |
| 650 | 7 | |a human herpesvirus 1 |2 cabt | |
| 650 | 7 | |a vaccination |2 cabt | |
| 650 | 7 | |a vaccines |2 cabt | |
| 650 | 7 | |a polymerase chain reaction |2 cabt | |
| 650 | 7 | |a sds-page |2 cabt | |
| 650 | 7 | |a western blotting |2 cabt | |
| 650 | 7 | |a immune response |2 cabt | |
| 650 | 7 | |a antibodies |2 cabt | |
| 650 | 7 | |a molecular genetics |2 cabt | |
| 650 | 7 | |a gene expression |2 cabt | |
| 650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Herpes-simplex-Virus |0 (DE-588)4137122-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Herpes simplex |0 (DE-588)4137123-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Entwicklung |0 (DE-588)4113450-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Immunreaktion |0 (DE-588)4133841-8 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Herpes-simplex-Virus |0 (DE-588)4137122-7 |D s |
| 689 | 0 | 1 | |a Immunreaktion |0 (DE-588)4133841-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Herpes simplex |0 (DE-588)4137123-9 |D s |
| 689 | 1 | 1 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 1 | 2 | |a Entwicklung |0 (DE-588)4113450-3 |D s |
| 689 | 1 | |5 DE-604 | |
| 856 | 4 | 2 | |m V:AT-OBV;B:AT-UBVUW |q text/plain |u http://media.obvsg.at/AC05035874-3001 |x VUW |3 Abstract |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-024482311 | ||
Datensatz im Suchindex
| _version_ | 1804148483244949504 |
|---|---|
| any_adam_object | |
| author | Model, Nina |
| author_facet | Model, Nina |
| author_role | aut |
| author_sort | Model, Nina |
| author_variant | n m nm |
| building | Verbundindex |
| bvnumber | BV039632217 |
| ctrlnum | (OCoLC)918103370 (DE-599)OBVAC05035874 |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02328nam a2200625 c 4500</leader><controlfield tag="001">BV039632217</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20120120 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">111012s2007 au ad|| m||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)918103370</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)OBVAC05035874</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">au</subfield><subfield code="c">AT</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-188</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Model, Nina</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="242" ind1="0" ind2="0"><subfield code="a">Immunologische Reaktivität gegen Herpes Simplex Virus Antigene in seropositiven Personen und Personen mit wiederkehrender HSV-2 Infektion</subfield><subfield code="y">ger</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immunologic reactivity to herpes simplex virus antigens in seropositive individuals and individuals with recurrent HSV-2 infection</subfield><subfield code="c">vorgelegt von Nina Model</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2007</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 158 Bl.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Zsfassung in dt. Sprache</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="a">Wien, Univ., Diss., 2007</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">viral diseases</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">herpesviridae</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">biotechnology</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">varicellovirus</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">human herpesvirus 1</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">vaccination</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">vaccines</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">polymerase chain reaction</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">sds-page</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">western blotting</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">immune response</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">antibodies</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">molecular genetics</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">gene expression</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Herpes-simplex-Virus</subfield><subfield code="0">(DE-588)4137122-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Herpes simplex</subfield><subfield code="0">(DE-588)4137123-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Entwicklung</subfield><subfield code="0">(DE-588)4113450-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immunreaktion</subfield><subfield code="0">(DE-588)4133841-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Herpes-simplex-Virus</subfield><subfield code="0">(DE-588)4137122-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Immunreaktion</subfield><subfield code="0">(DE-588)4133841-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Herpes simplex</subfield><subfield code="0">(DE-588)4137123-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Entwicklung</subfield><subfield code="0">(DE-588)4113450-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">V:AT-OBV;B:AT-UBVUW</subfield><subfield code="q">text/plain</subfield><subfield code="u">http://media.obvsg.at/AC05035874-3001</subfield><subfield code="x">VUW</subfield><subfield code="3">Abstract</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-024482311</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV039632217 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T00:07:51Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-024482311 |
| oclc_num | 918103370 |
| open_access_boolean | |
| owner | DE-188 |
| owner_facet | DE-188 |
| physical | XI, 158 Bl. Ill., graph. Darst. |
| publishDate | 2007 |
| publishDateSearch | 2007 |
| publishDateSort | 2007 |
| record_format | marc |
| spelling | Model, Nina Verfasser aut Immunologische Reaktivität gegen Herpes Simplex Virus Antigene in seropositiven Personen und Personen mit wiederkehrender HSV-2 Infektion ger Immunologic reactivity to herpes simplex virus antigens in seropositive individuals and individuals with recurrent HSV-2 infection vorgelegt von Nina Model 2007 XI, 158 Bl. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Zsfassung in dt. Sprache Wien, Univ., Diss., 2007 viral diseases cabt herpesviridae cabt biotechnology cabt varicellovirus cabt human herpesvirus 1 cabt vaccination cabt vaccines cabt polymerase chain reaction cabt sds-page cabt western blotting cabt immune response cabt antibodies cabt molecular genetics cabt gene expression cabt Impfstoff (DE-588)4026655-2 gnd rswk-swf Herpes-simplex-Virus (DE-588)4137122-7 gnd rswk-swf Herpes simplex (DE-588)4137123-9 gnd rswk-swf Entwicklung (DE-588)4113450-3 gnd rswk-swf Immunreaktion (DE-588)4133841-8 gnd rswk-swf (DE-588)4113937-9 Hochschulschrift gnd-content Herpes-simplex-Virus (DE-588)4137122-7 s Immunreaktion (DE-588)4133841-8 s DE-604 Herpes simplex (DE-588)4137123-9 s Impfstoff (DE-588)4026655-2 s Entwicklung (DE-588)4113450-3 s V:AT-OBV;B:AT-UBVUW text/plain http://media.obvsg.at/AC05035874-3001 VUW Abstract |
| spellingShingle | Model, Nina Immunologic reactivity to herpes simplex virus antigens in seropositive individuals and individuals with recurrent HSV-2 infection viral diseases cabt herpesviridae cabt biotechnology cabt varicellovirus cabt human herpesvirus 1 cabt vaccination cabt vaccines cabt polymerase chain reaction cabt sds-page cabt western blotting cabt immune response cabt antibodies cabt molecular genetics cabt gene expression cabt Impfstoff (DE-588)4026655-2 gnd Herpes-simplex-Virus (DE-588)4137122-7 gnd Herpes simplex (DE-588)4137123-9 gnd Entwicklung (DE-588)4113450-3 gnd Immunreaktion (DE-588)4133841-8 gnd |
| subject_GND | (DE-588)4026655-2 (DE-588)4137122-7 (DE-588)4137123-9 (DE-588)4113450-3 (DE-588)4133841-8 (DE-588)4113937-9 |
| title | Immunologic reactivity to herpes simplex virus antigens in seropositive individuals and individuals with recurrent HSV-2 infection |
| title_auth | Immunologic reactivity to herpes simplex virus antigens in seropositive individuals and individuals with recurrent HSV-2 infection |
| title_exact_search | Immunologic reactivity to herpes simplex virus antigens in seropositive individuals and individuals with recurrent HSV-2 infection |
| title_full | Immunologic reactivity to herpes simplex virus antigens in seropositive individuals and individuals with recurrent HSV-2 infection vorgelegt von Nina Model |
| title_fullStr | Immunologic reactivity to herpes simplex virus antigens in seropositive individuals and individuals with recurrent HSV-2 infection vorgelegt von Nina Model |
| title_full_unstemmed | Immunologic reactivity to herpes simplex virus antigens in seropositive individuals and individuals with recurrent HSV-2 infection vorgelegt von Nina Model |
| title_short | Immunologic reactivity to herpes simplex virus antigens in seropositive individuals and individuals with recurrent HSV-2 infection |
| title_sort | immunologic reactivity to herpes simplex virus antigens in seropositive individuals and individuals with recurrent hsv 2 infection |
| topic | viral diseases cabt herpesviridae cabt biotechnology cabt varicellovirus cabt human herpesvirus 1 cabt vaccination cabt vaccines cabt polymerase chain reaction cabt sds-page cabt western blotting cabt immune response cabt antibodies cabt molecular genetics cabt gene expression cabt Impfstoff (DE-588)4026655-2 gnd Herpes-simplex-Virus (DE-588)4137122-7 gnd Herpes simplex (DE-588)4137123-9 gnd Entwicklung (DE-588)4113450-3 gnd Immunreaktion (DE-588)4133841-8 gnd |
| topic_facet | viral diseases herpesviridae biotechnology varicellovirus human herpesvirus 1 vaccination vaccines polymerase chain reaction sds-page western blotting immune response antibodies molecular genetics gene expression Impfstoff Herpes-simplex-Virus Herpes simplex Entwicklung Immunreaktion Hochschulschrift |
| url | http://media.obvsg.at/AC05035874-3001 |
| work_keys_str_mv | AT modelnina immunologicreactivitytoherpessimplexvirusantigensinseropositiveindividualsandindividualswithrecurrenthsv2infection |